{"status": "ok", "totalResults": 103, "articles": [{"source": {"id": null, "name": "Moneycontrol"}, "author": "Hindi.Moneycontrol.com Team, Moneycontrol Hindi", "title": "Warren Buffet \u0915\u0940 \u0915\u0902\u092a\u0928\u0940 \u092c\u0930\u094d\u0915\u0936\u093e\u092f\u0930 \u0915\u0940 \u0918\u091f\u0940 53% \u0915\u092e\u093e\u0908, \u0932\u0902\u092c\u0947 \u0938\u092e\u092f \u092c\u093e\u0926 \u0905\u092a\u0928\u0947 \u0915\u0948\u0936 \u092d\u0902\u0921\u093e\u0930 \u092e\u0947\u0902 \u0938\u0947 40 \u0905\u0930\u092c \u0921\u0949\u0932\u0930 \u0915\u093f\u092f\u093e \u0916\u0930\u094d\u091a", "description": "\u0926\u093f\u0917\u094d\u0917\u091c \u0905\u092e\u0947\u0930\u093f\u0915\u0940 \u0928\u093f\u0935\u0947\u0936\u0915 \u0935\u0949\u0930\u0947\u0928 \u092c\u092b\u0947 (Warren Buffet) \u0915\u0940 \u0915\u0902\u092a\u0928\u0940 \u0935\u0930\u094d\u0915\u0936\u093e\u092f\u0930 \u0939\u0948\u0925\u0935\u0947 (Berkshire Hathaway) \u0915\u0940 \u0915\u092e\u093e\u0908 \u092e\u093e\u0930\u094d\u091a \u0924\u093f\u092e\u093e\u0939\u0940 \u092e\u0947\u0902 \u0915\u0930\u0940\u092c 53 \u092b\u0940\u0938\u0926\u0940 \u0918\u091f\u0940 \u0939\u0948\u0964 \u0939\u093e\u0932\u093e\u0902\u0915\u093f \u0907\u0938 \u0924\u093f\u092e\u093e\u0939\u0940 \u0915\u0947 \u0926\u094c\u0930\u093e\u0928 \u0935\u0949\u0930\u0947\u0928 \u092c\u092b\u0947 \u0928\u0947 \u0905\u092a\u0928\u0947 \u092a\u093e\u0938 \u0930\u0916\u0947 \u0932\u0902\u092c\u0947 \u0938\u092e\u092f \u0938\u0947 \u0930\u0916\u0947 \u0935\u093f\u0936\u093e\u0932 \u0915\u0948\u0936 \u092d\u0902\u0921\u093e\u0930 \u0915\u094b \u092d\u0940 \u0915\u092e \u0915\u093f\u092f\u093e \u0939\u0948 \u0914\u0930 \u092e\u093e\u0930\u094d\u091a \u0924\u093f\u092e\u093e\u0939\u0940 \u092e\u2026", "url": "http://hindi.moneycontrol.com/news/business/warren-buffet-berkshire-sees-53-percent-drop-in-first-quarter-income-operating-results-flat-556091.html", "urlToImage": "https://images.moneycontrol.com/static-hindinews/2022/04/warrentbuffet-770x431.jpg", "publishedAt": "2022-04-30T17:24:38Z", "content": "(Warren Buffet) (Berkshire Hathaway) 53 51 , \r\n 5.46 3.702 11.7 7.638 \r\n-\u00a0Jeff Bezos 20 , \r\n : , \r\n Alleghany 11.6 HP Inc 4.2 \r\n Chevron 26 , 4.5 Chevron Occidental , , 40 \r\n 1.58 , 4.7"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Laurus Labs: target of Rs 735: Sharekhan", "description": "Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 735 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-laurus-labs-target-of-rs-735-sharekhan-3-8435261.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/01/Buy-770x433.png", "publishedAt": "2022-04-30T16:44:16Z", "content": "Sharekhan's research report on Laurus Labs\r\nLaurus Labs reported muted results for Q4FY22 with PAT marginally missing estimates. Management commentary on outlook for the Synthesis and FDF segments wa\u2026 [+932 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Biocon: target of Rs 420: Sharekhan", "description": "Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 420 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-biocon-target-of-rs-420-sharekhan-2-8435251.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-04-30T16:43:47Z", "content": "Sharekhan's research report on Biocon\r\nBiocon reported strong numbers and results were in line with estimates. The Biologics segment drove the strong show, while generics and research services also s\u2026 [+964 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Coromandel International: target of Rs 1070: Sharekhan", "description": "Sharekhan is bullish on Coromandel International has recommended buy rating on the stock with a target price of Rs 1070 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-coromandel-international-target-of-rs-1070-sharekhan-3-8435241.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_3-1-770x433.jpg", "publishedAt": "2022-04-30T16:43:39Z", "content": "Sharekhan's research report on Coromandel International\r\nQ4FY2022 results were strong with 51% beat in PAT at Rs. 290 crore (up 86% y-o-y) due to sharp beat in EBITDA margin and higher other income. \u2026 [+1319 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy IndusInd Bank: target of Rs 1150: Sharekhan", "description": "Sharekhan is bullish on IndusInd Bank has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-indusind-bank-target-of-rs-1150-sharekhan-2-8435231.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-04-30T16:43:28Z", "content": "Sharekhan's research report on IndusInd Bank\r\nIndusInd Bank reported a PAT of Rs.1,361 crore in line with the consensus estimates. PAT grew by 55% y-o-y / 17% q-o-q mainly due to lower provisions whi\u2026 [+1094 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy UltraTech Cement: target of Rs 8600: Sharekhan", "description": "Sharekhan is bullish on UltraTech Cement has recommended buy rating on the stock with a target price of Rs 8600 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-ultratech-cement-target-of-rs-8600-sharekhan-8435221.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-04-30T16:43:16Z", "content": "Sharekhan's research report on UltraTech Cement\r\nIn Q4FY2022, UltraTech reported broadly in-line performance as marginally lower-than-expected volumes were offset by higher realisation. Consolidated \u2026 [+1013 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Maruti Suzuki India: target of Rs 9820: Sharekhan", "description": "Sharekhan is bullish on Maruti Suzuki India has recommended buy rating on the stock with a target price of Rs 9820 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-maruti-suzuki-india-target-of-rs-9820-sharekhan-8435201.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/01/Buy-770x433.png", "publishedAt": "2022-04-30T16:43:03Z", "content": "Sharekhan's research report on Maruti Suzuki India\r\nFor Q4FY2022, Maruti Suzuki India Limiteds (MSIL) operational performance exceeded expectations, driven by operating leverage benefits, lower sales\u2026 [+921 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Hold Wipro: target of Rs 580: Sharekhan", "description": "Sharekhan recommended Hold rating on Wipro with a target price of Rs 580 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/hold-wipro-target-of-rs-580-sharekhan-8435271.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/hold-1-770x433.jpg", "publishedAt": "2022-04-30T16:40:23Z", "content": "Sharekhan's research report on Wipro\r\nFor Q4FY22, Wipros OPM lagged our expectations, while revenue was in line with estimates. Net employee additions, client mining, logo additions and deal ACVs sta\u2026 [+1089 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Hindi.Moneycontrol.com Team, Moneycontrol Hindi", "title": "Gorakhnath Temple Attack: \u0906\u0930\u094b\u092a\u0940 \u092e\u0941\u0930\u094d\u0924\u091c\u093e \u0905\u092c\u094d\u092c\u093e\u0938\u0940 \u0928\u0947 2020 \u092e\u0947\u0902 \u0932\u0940 \u0925\u0940 ISIS \u0915\u0940 \u0936\u092a\u0925- UP \u092a\u0941\u0932\u093f\u0938", "description": "Gorakhnath Temple Attack: \u0917\u094b\u0930\u0916\u0928\u093e\u0925 \u092e\u0902\u0926\u093f\u0930 (Gorakhnath Mandir) \u092e\u0947\u0902 \u0938\u0941\u0930\u0915\u094d\u0937\u093e\u0915\u0930\u094d\u092e\u093f\u092f\u094b\u0902 \u092a\u0930 \u0939\u092e\u0932\u0947 \u0915\u0947 \u0938\u093f\u0932\u0938\u093f\u0932\u0947 \u092e\u0947\u0902 \u0917\u093f\u0930\u092b\u094d\u0924\u093e\u0930 \u092e\u0941\u0930\u094d\u0924\u091c\u093e \u0905\u092c\u094d\u092c\u093e\u0938\u0940 (Murtaza Abbasi) \u0928\u0947 \u0926\u094b \u0938\u093e\u0932 \u092a\u0939\u0932\u0947 ISIS \u0915\u0940 \u0936\u092a\u0925 \u0932\u0940 \u0925\u0940\u0964 \u0938\u093e\u0925 \u0939\u0940 \u0907\u0938\u0928\u0947 \u092f\u0942\u0930\u094b\u092a\u0940\u092f \u0926\u0947\u0936\u094b\u0902 \u0915\u0947 \u0938\u093e\u0925-\u0938\u093e\u0925 \u0905\u092e\u0947\u0930\u093f\u0915\u093e \u092e\u0947\u0902 \u092d\u0940 \u0905\u092a\u0928\u0947 \u0938\u092e\u0930\u094d\u0925\u0915\u094b\u0902 \u0915\u094b \u0935\u093f\u0924\u094d\u0924\u0940\u092f \u092e\u0926\u0926\u2026", "url": "http://hindi.moneycontrol.com/news/india/gorakhnath-temple-attack-accused-murtaza-abbasi-took-oath-of-isis-in-2020-up-police-556071.html", "urlToImage": "https://images.moneycontrol.com/static-hindinews/2022/04/GorakhpurMurtaza775-770x430.jpg", "publishedAt": "2022-04-30T16:35:39Z", "content": "Gorakhnath Temple Attack: (Gorakhnath Mandir) (Murtaza Abbasi) ISIS - (UP Police) (ATS) \r\n ( ) , \" ATS ISIS , ISIS ISIS \"\r\nISIS 2020 ADG ISIS 2014 \r\n UP ATS ISIS , ISIS ISIS ADG L&amp;O UP @PrashantK\u2026 [+164 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Neutral Biocon; target of Rs 410: Motilal Oswal", "description": "Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 410 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/neutral-biocon-target-of-rs-410-motilal-oswal-8435131.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_3-1-770x433.jpg", "publishedAt": "2022-04-30T16:25:15Z", "content": "Motilal Oswal's research report on Biocon\r\nBiocon (BIOS) delivered operationally in-line 4QFY22. The performance was healthy in generics and research services, while biologics sales have been steady \u2026 [+861 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Maruti Suzuki; target of Rs 10000: Motilal Oswal", "description": "Motilal Oswal is bullish on Maruti Suzuki recommended buy rating on the stock with a target price of Rs 10000 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-maruti-suzuki-target-of-rs-10000-motilal-oswal-8435151.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-04-30T16:25:04Z", "content": "Motilal Oswal's research report on Maruti Suzuki\r\nMSIL reported a strong beat in 4QFY22, led by stable commodity prices and lower discounts. Favorable product lifecycle will drive volumes, market sha\u2026 [+741 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Mphasis; target of Rs 3200: Motilal Oswal", "description": "Motilal Oswal is bullish on Mphasis recommended buy rating on the stock with a target price of Rs 3200 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-mphasis-target-of-rs-3200-motilal-oswal-8435171.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_3-1-770x433.jpg", "publishedAt": "2022-04-30T16:24:43Z", "content": "Motilal Oswal's research report on Mphasis\r\nMPHL's 4QFY22 performance was led by a 4.7% constant currency (CC) QoQ growth in the Direct business. DXC was marginally up (+1.1% QoQ CC) and now accounts\u2026 [+1235 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Shriram Transport Finance; target of Rs 1500: Motilal Oswal", "description": "Motilal Oswal is bullish on Shriram Transport Finance recommended buy rating on the stock with a target price of Rs 1500 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-shriram-transport-finance-target-of-rs-1500-motilal-oswal-8435181.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-04-30T16:24:20Z", "content": "Motilal Oswal's research report on Shriram Transport Finance\r\nSHTF earnings were buoyed by interest income write-back of ~INR1.1b and tax reversal of INR820m, which resulted in a lower effective rate\u2026 [+1211 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Galaxy Surfactants; target of Rs 3632: Motilal Oswal", "description": "Motilal Oswal is bullish on Galaxy Surfactants recommended buy rating on the stock with a target price of Rs 3632 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-galaxy-surfactants-target-of-rs-3632-motilal-oswal-2-8435191.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-04-30T16:23:38Z", "content": "Motilal Oswal's research report on Galaxy Surfactants\r\nGALSURF is one of the leading players in the world of Surfactants and Specialty Care ingredients, exclusively focused on catering to the Home an\u2026 [+847 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Hindi.Moneycontrol.com Team, Moneycontrol Hindi", "title": "Rakesh Jhunjhunwala \u0915\u0947 \u0907\u0928 \u0926\u094b \u0936\u0947\u092f\u0930\u094b\u0902 \u092a\u0930 \u092e\u093f\u0932 \u0938\u0915\u0924\u093e \u0939\u0948 \u0905\u091a\u094d\u091b\u093e \u0930\u093f\u091f\u0930\u094d\u0928, \u092e\u093e\u0930\u094d\u091a \u0924\u093f\u092e\u093e\u0939\u0940 \u0915\u0947 \u0928\u0924\u0940\u091c\u094b\u0902 \u0915\u0947 \u092c\u093e\u0926 \u092c\u0941\u0932\u093f\u0936 \u0939\u0948\u0902 \u090f\u0915\u094d\u0938\u092a\u0930\u094d\u091f\u094d\u0938", "description": "\u0930\u093e\u0915\u0947\u0936 \u091d\u0941\u0928\u091d\u0941\u0928\u0935\u093e\u0932\u093e (Rakesh Jhunjhunwala) \u0915\u0947 \u0928\u093f\u0935\u0947\u0936 \u0935\u093e\u0932\u0947 \u091f\u093e\u091f\u093e \u0917\u094d\u0930\u0941\u092a \u0915\u0947 \u0926\u094b \u0936\u0947\u092f\u0930\u094b\u0902 (Tata Stocks) \u092a\u0930 \u090f\u0915\u094d\u0938\u092a\u0930\u094d\u091f \u092c\u0941\u0932\u093f\u0936 \u0926\u093f\u0916 \u0930\u0939\u0947 \u0939\u0948\u0902\u0964 \u092f\u0947 \u0926\u094b \u0936\u0947\u092f\u0930 \u0939\u0948\u0902- \u0907\u0902\u0921\u093f\u092f\u0928 \u0939\u094b\u091f\u0932\u094d\u0938 \u0915\u0902\u092a\u0928\u0940 (Indian Hotels Company) \u0914\u0930 \u091f\u093e\u091f\u093e \u0915\u092e\u094d\u092f\u0941\u0928\u093f\u0915\u0947\u0936\u0902\u0938 (Tata Communications) \u0936\u093e\u092e\u093f\u0932\u0964 \u0907\u0928 \u0926\u094b \u0936\u0947\u092f\u0930\u094b\u0902 \u0928\u0947 \u092a\u0939\u0932\u0947 \u0939\u0940 \u092e\u0939\u093e\u2026", "url": "http://hindi.moneycontrol.com/news/markets/rakesh-jhunjhunwala-portfolio-experts-optimistic-on-two-tata-stocks-post-q4-earnings-556051.html", "urlToImage": "https://images.moneycontrol.com/static-hindinews/2022/03/rakeshjhunjhunwala-9.jpg", "publishedAt": "2022-04-30T16:08:55Z", "content": "(Rakesh Jhunjhunwala) (Tata Stocks) - (Indian Hotels Company) (Tata Communications) \r\n -\r\n97.72 , 71.57 872.08 , 615.02 \r\n ICICI Securities 285 292 2\r\n -\u00a0Jeff Bezos 20 , \r\n 3.9 256.25 137 40 \r\n31 , 3\u2026 [+123 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Hold Biocon; target of Rs 380: ICICI Direct", "description": "ICICI Direct recommended hold rating on Biocon with a target price of Rs 380 in its research report dated April 30, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/hold-biocon-target-of-rs-380-icici-direct-8435081.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/hold-3-770x433.jpg", "publishedAt": "2022-04-30T15:20:55Z", "content": "ICICI Direct's research report on Biocon\r\nBiocon mainly operates in biologics (biosimilars), small molecules (generics), branded formulations and contract research (Syngene). Biocon Biologics (BBL), \u2026 [+1240 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Laurus Labs; target of Rs 690: ICICI Direct", "description": "ICICI Direct is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 690 in its research report dated April 30, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-laurus-labs-target-of-rs-690-icici-direct-8435071.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-04-30T15:17:04Z", "content": "ICICI Direct's research report on Laurus Labs\r\nLaurus Labs operates in the segment of generic APIs &amp; FDFs (formulations), custom synthesis and biotechnology. Major focus in APIs is on ARV, oncolo\u2026 [+892 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Mphasis; target of Rs 3379: Prabhudas Lilladher", "description": "Prabhudas Lilladher is bullish on Mphasis has recommended buy rating on the stock with a target price of Rs 3379 in its research report dated April 29, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-mphasis-target-of-rs-3379-prabhudas-lilladher-8435031.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/01/Buy-770x433.png", "publishedAt": "2022-04-30T15:10:52Z", "content": "Prabhudas Lilladher's research report on Mphasis\r\nMphasis Q4 performance was in-line with consensus estimates. Management guided industry leading growth in Direct business to continue given -1) FY22 \u2026 [+1791 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy IndusInd Bank; target of Rs 1297: Prabhudas Lilladher", "description": "Prabhudas Lilladher is bullish on IndusInd Bank has recommended buy rating on the stock with a target price of Rs 1297 in its research report dated April 30, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-indusind-bank-target-of-rs-1297-prabhudas-lilladher-8435051.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-04-30T15:10:32Z", "content": "Prabhudas Lilladher's research report on IndusInd Bank\r\nIIBs earnings at Rs13.6bn (PLe: Rs11.7bn) were a beat to estimates driven by higher loan growth of 12.4% YoY and the resultant fee income, bett\u2026 [+1392 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Hindustan Unilever; target of Rs 2834: KR Choksey", "description": "KR Choksey is bullish on Hindustan Unilever has recommended buy rating on the stock with a target price of Rs 2834 in its research report dated April 30, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-hindustan-unilever-target-of-rs-2834-kr-choksey-8435011.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-04-30T15:04:04Z", "content": "KR Choksey's research report on Hindustan Unilever\r\nFor Q4FY22, HUVR reported revenue growth of 10.7% YoY (2.4% QoQ) to INR 1,37,670 Mn driven by price hikes across categories. Volume remained flat f\u2026 [+1330 chars]"}]}